AbbVie Inc. (ABBV)

ABBV · Health Care · United States

AbbVie Inc. (ABBV) is a company in the Health Care sector, based in United States. The stock is held in 20 ETFs we track – with its largest weight of 7.57 % in XUHL (msci-usa-health-care). Anyone holding one of these ETFs also owns a small indirect stake in AbbVie.

Above-average ETF coverage: 20 of the 95 ETFs we cover hold AbbVie, spread across 9 indices. That puts the stock in more ETFs than 82.9 % of the 4,334 stocks we cover.

Held in20 ETFs

Highest weight7.57 %

Indices9

SectorHealth Care

CountryUnited States

ISINUS00287Y1091

WKNA1J84E

Data note 1

Price chart

Data note 2

Performance

Performance
Year to date	+14.9 %	1 year	+21.4 %
1 month	+4.9 %	3 months	+18.7 %
Calendar year 2025	+28.6 %

52W

Data note 3

Measured in euros, AbbVie returned +17.0 % year to date and +24.2 % over one year. The gap to the dollar figures above comes from the exchange rate alone: each daily price is converted at the ECB euro reference rate for the same day.

Data note 4

Risk metrics

Max drawdown-21.5 %

Volatility p.a.26.9 %

Data note 5

Below peak-1.3 %

Beta to S&P 500-0.10

Correlation to S&P 500-0.05

The close on Sep 16, 2026 was 1.3 % below the highest close since Jul 11, 2024, reached on Aug 19, 2026. Over the last 252 trading days, on days when the S&P 500 rose or fell 1 %, AbbVie moved on average 0.10 % in the opposite direction. The correlation of -0.05 shows how reliable that average is: the broad market explained only a small share of the daily moves.

Data note 6

Correlated with

The strongest co-movers on top, the most inverse below. Low or negative values improve portfolio diversification.

Correlated with
Instrument	r	−1 … +1
Johnson & Johnson	+0.65
Amgen Inc.	+0.60
Vertex Pharmaceuticals Incorporated	+0.60
Eli Lilly and Company	+0.59
Bristol-Myers Squibb Company	+0.57
Royalty Pharma Plc Class A	+0.55
Broadcom Inc.	-0.56
CoreWeave Inc. Class A	-0.47
Seagate Technology Holdings plc	-0.46

Data note 7

Key financials

Latest reported fiscal year (FY2025, period end 2025-12-31) as filed with the SEC.

Revenue61.2 bn $

Net income4.2 bn $

Diluted EPS2.36 $

Net margin6.9 %

Return on equity-129.2 %

Equity ratio-2.4 %

Revenue growth+8.6 %

Revenue and profit by fiscal year
Fiscal year	Revenue	Net income	Margin
FY2023	54.3	4.9	9.0 %
FY2024	56.3	4.3	7.6 %
FY2025	61.2	4.2	6.9 %

Data note 8

Held in these ETFs

Held in these ETFs
ETF	Index	Weight	per €1,000 in the ETF
XUHL / XUHC	msci-usa-health-care	7.57 %	€75.70
SPFS	msci-world-health-care	5.58 %	€55.80
XDWH	msci-world-health-care	5.57 %	€55.70
SPYL / SPY5	sp500	0.71 %	€7.10
SXR8	sp500	0.71 %	€7.10
XD9U / XD9D	msci-usa	0.71 %	€7.10
XDEB	msci-world-minimum-volatility	0.61 %	€6.10
SWWD	msci-world	0.52 %	€5.20
SPPW	msci-world	0.52 %	€5.20
EUNL	msci-world	0.51 %	€5.10
XDWD / XDWL	msci-world	0.51 %	€5.10
WIMI	msci-world-imi	0.46 %	€4.60
SPYY	msci-acwi	0.45 %	€4.50
IUSQ	msci-acwi	0.45 %	€4.50
SPYI / SPSA	msci-acwi-imi	0.42 %	€4.20

Data note 9

The last column turns the weight into euros: this much of €1,000 invested in one of these funds is allocated to AbbVie as of the fund's latest holdings list.

Weight in EUNL since 2019

Sep 30, 2019Sep 16, 2026

In EUNL, a fund tracking the MSCI World, AbbVie had a weight of 0.27 % on Sep 30, 2019 and 0.51 % on Sep 16, 2026. Its share peaked at 0.56 % on Dec 30, 2022. The weight rises and falls with the stock's price relative to the other index members, and it also shifts when the index provider changes the composition.

Data note 10

How much AbbVie Inc. overlaps with other holdings in a portfolio is shown by the Portfolio X-Ray and the ETF overlap check.

Stocks with similar ETF exposure

Names that reach a portfolio through largely the same funds as AbbVie — the figure counts the ETFs holding both.

Data note 11

Key figures side by side

Key figures compared with stocks of similar ETF exposure
Stock	1 year	Volatility p.a.	Net margin	Revenue growth
AbbVie	+21.4 %	26.9 %	6.9 %	+8.6 %
Abbott Laboratories	-22.9 %	24.1 %	14.7 %	+5.7 %
Cardinal Health	+56.7 %	26.4 %	0.7 %	-1.9 %
Cencora	+9.8 %	26.4 %	0.5 %	+9.3 %
McKesson Corporation	+28.0 %	28.6 %	1.2 %	+12.4 %
Edwards Lifesciences Corporation	+18.9 %	25.1 %	17.7 %	+11.5 %
HCA Healthcare Inc	+7.7 %	29.1 %	9.0 %	+7.1 %
Eli Lilly and Company	+48.8 %	38.3 %	31.7 %	+44.7 %
Boston Scientific Corporation	-55.6 %	31.0 %	–	+19.9 %

Return and volatility from our daily closing prices in US dollars; margin and growth from the latest SEC annual filing. Fiscal years do not all end on the same date.